Are Avion ever going to start the phase II/III…. |
STX, SBTX, BT, VOD, GDR, CPI? Need any more?
It's taken longer than expected here, but it will come.
Have a great day in your bedsit. |
Socionomics, most of the shares that you have recommended have turned out to be duds. |
So so close now! |
500 - Gap the stock!
Could be tomorrow AM. Everything crossed for all genuine gamblers. |
It isn't even the year, let alone the week. |
It feels like this is the week. We are so close now. |
+ 100 : I need shares. |
It seems as Jane Austin wrote in Pride and Prejudice and paraphrasing:
"It is a truth universally acknowledged that anyone who makes a future share price (direction) prediction may be both right and wrong, but that they will only ever highlight one of those conditions."
Of course the algo driven trading knows where to put the price but for IMM this isn't at least for now much of a issue although it seems someone is keeping it in a range.
PS agree with Nobby in 38701. |
Good banter guys. Let's keep this thread informative and humorous. Nobby versus Socio. Who will prove to be right and over what time frame. Will Nobby turn positive?Looking at the depth of the red next to the IMM part of my portfolio I'm rooting for Socio and wondering whether to double my holding at these levels in a reckless attempt to salvage something from this otherwise disastrous investment (to date". |
So keep your money in your pocket then Nobby 😎 |
Well the chart shows the price is most definitely in a long term downtrend and short term is in the middle of a trading range. That does not indicate a rise is imminent to me…. |
Not everyone who picks up a paintbrush is a Picasso. |
I think the gerbil is likely to do better as it isn't subject to your biases. |
All of which just goes to show how pointless it is to rely on charts.
Two posters here manage to draw very different conclusions from the exact same graph.
A graph, at that, which is backwards-looking.
You might as well ask your pet gerbil to forecast. |
Thanks for the reply….but I absolutely don’t see that. From my view the price is in the middle of a trading range and could go either way…. |
Nobby, so far as I can ascertain on charting, the share price is sitting right on the resistance / support level. If it rises the top of the trading range will be 2.5 p. In candle chart, it is a white candle (rising) so I am inclined to say that it will rise to 2.5 p in the next cycle. |
The current chart looks poor to me; I certainly wouldn’t buy after glancing at it!
Please explain why you think it’s positive…. |
That's because they only tell you what's already happened. |
Wait and see fellas. The charts never lie. |
Thanks Nobby - much appreciated.No logical reason why there should be any upward movement of the share price in the near future then.Time to go back to sleep |
Well they haven’t even submitted the IND for the CIDP indication so that’s ages away from starting. As for SLE, well that’s down to Avion. It’s always been a concern of mine that Avion have no experience in SLE. It’s a very complicated indication with a high placebo response, the possibility of other drugs such as steroids confounding the results and a heterogeneous range of symptoms. So clearly Avion are struggling to get it off the ground which is why it would appear that the earliest results could be out is 2027. Of course we haven’t seen the protocol yet so don’t know the length of dosing, which makes it a little difficult to predict. In addition there is dose ranging incorporated in the design which adds complexity.
So all in all it’s about as clear as mud at the moment…. |
Hi NobbyAlthough I remain a holder it's not a share I have really followed over the last couple of years so any chance you could give me a brief summary of where we are on the long delayed phase 3 approval application.Btw Socio et moi are doing quite nicely on another pharma tiddler STX, although granted it does have an FDA approved product. |